NEW YORK, Aug. 31, 2023 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) alleging that the Company violated federal securities laws.
Class Period: January 28, 2021 to July 28, 2023
Lead Plaintiff Deadline: October 2, 2023
No obligation or cost to you.
Learn more about your recoverable losses in APLS:
https://www.kleinstocklaw.com/pslra-1/apellis-lawsuit-loss-submission-form?id=45508&from=3
Apellis Pharmaceuticals, Inc. NEWS - APLS NEWS
CLASS ACTION CASE DETAILS: The filed complaint alleges that Apellis Pharmaceuticals, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) the ...
APLS) Shareholders>Full story available on Benzinga.com